Biotech Lexeo Therapeutics (LXEO proposed) launched its $126 million IPO today -Monday, Oct. 30, 2023 – for pricing this week. Lexeo Therapeutics disclosed its IPO terms – 9.0 million shares at $13.00 to $15.00 – in an S-1/A filing early today. The news injected some life – and the only $100-million-plus IPO – into the […]
October 30, 2023 Read MoreMach Natural Resources LP (MNR), an Oklahoma City-based oil and natural gas partnership, priced its IPO at $19.00 – the low end of its $19.00-to-$21.00 range – on Tuesday night (Oct. 24, 2023). The profitable oil and gas drilling company priced 10 million units – the same number in the prospectus – at $19.00 to raise […]
October 24, 2023 Read MoreOklahoma City-based Mach Natural Resources LP (MNR proposed), an oil and natural gas limited partnership, is the featured attraction this week. Mach is the only big traditional deal on the IPO Calendar for the week of Oct. 23, 2023. Mach is offering 10 million common units at $19.00 to $21.00 to raise $200 million – […]
October 23, 2023 Read MoreFrench biotech Abivax S.A. (ABVX) priced its NASDAQ uplisting – a U.S. public offering of 18.7 million American Depositary Shares (ADS) – at $11.60 – the low end of its range – to raise $216.91 million on Thursday night (Oct. 19, 2023). The price range was $11.60 to $13.00 for the ADS. Abivax S.A.’s ADS […]
October 20, 2023 Read MoreTo the moon: Singapore-based WeBuy Global Ltd. (WBUY) shares jumped to $10.00 – for a moonshot gain of 150 percent from their $4.00 IPO price – at around 12:45 p.m. EDT today in their NASDAQ debut. Volume was about 1.09 million shares. The stock hit its intraday high at $10.84 at around 3:10 p.m. EDT. Within a […]
October 19, 2023 Read MoreNorthann Corp. (NCL), a California manufacturer and distributor of 3D-printed vinyl flooring, priced its sharply downsized IPO at $5.00 – the high end of its $3.00-to-$5.00 range – to raise $6.0 million on Wednesday night (Oct. 18, 2023). The company cut the number of shares by 60 percent – to 1.2 million shares – down from […]
Read MoreAbivax S.A., a French biotech whose ulcerative colitis drug candidate is in Phase 3 clinical trials, aims to raise $250 million in its NASDAQ uplisting this week. Abivax (ABVX proposed) launched its U.S. public offering of 18.68 million American Depositary Shares (ADS) on Monday (Oct. 16, 2023) by disclosing terms and starting its roadshow. The […]
October 17, 2023 Read MoreBirkenstock Holding plc (BIRK) priced its IPO at $46.00 – just below its $46.50 mid-point – on 32.26 million shares – the same number in the prospectus – to raise $1.5 billion, the company said tonight. The IPO’s price range was $44.00 to $49.00. The profitable Birkenstock Holding is the British parent of the iconic […]
October 10, 2023 Read MoreBirkenstock is getting ready to walk the IPO runway. Wall Street hopes that this will be a victory stroll for Birkenstock Holding plc (BIRK proposed) – the British parent of the iconic German sandal company. The sandals’ design heritage goes back to 1774. “Barbie” wore a pair of light pink leather Birkenstock Arizona slides in […]
October 9, 2023 Read MoreBankers priced two SPAC IPOs Thursday night (Oct. 5, 2023): Quetta Acquisition Corp. (QETAU) – 6.0 million units at $10.00 each – and Spark I Acquisition Corp. (SPKLU) – 10.0 million units at $10.00 each. These are the first blank check companies to go public since August – bringing the SPAC IPO count to 24 […]
October 6, 2023 Read More